Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
MedTech
JPM: Illumina working with China on export troubles, CEO says
Looking for a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the country’s Unreliable Entities List.
Ben Adams
Jan 14, 2026 8:25am
Takeda leader says AI gave early-stage asset a 'phoenix' rebirth
Jan 13, 2026 6:16am
Lynk targets the JAK pot with phase 3 rheumatoid arthritis win
Jan 12, 2026 8:45am
Flagship CEO warns Trump admin is 'undoing' scientific method
Jan 12, 2026 5:00am
AirNexis swoops in with $200M series A for COPD asset
Jan 9, 2026 11:01am
Illumina hires former NHGRI Director Eric Green as CMO
Jan 9, 2026 3:15am
